KAS
HAE icon

Kemnay Advisory Services’s Haemonetics HAE Stock Holding History

Kemnay Advisory Services’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7K Sell
316
-34
-10% -$2.18K ﹤0.01% 637
2026
Q1 		$19.7K Buy
350
+25
+8% +$1.63K ﹤0.01% 700
2025
Q4 		$26K Buy
+325
New +$21.8K ﹤0.01% 470

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kemnay Advisory Services's HAE Position: Q2 2026 in Review

Kemnay Advisory Services reduced its Haemonetics (HAE) stake by 9.7% in Q2 2026, selling an estimated $2.18K and leaving 316 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Kemnay Advisory Services first reported a position in HAE in Q4 2025 and has held it in 3 quarters since. The position peaked at $26K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Kemnay Advisory Services held 316 shares of Haemonetics worth $23.7K as of Q2 2026.
  • Kemnay Advisory Services sold 34 Haemonetics shares in Q2 2026, an estimated $2.18K.
  • Haemonetics made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #637 holding.
  • Kemnay Advisory Services first reported a position in Haemonetics in Q4 2025 and has held it in 3 quarters since.
  • Kemnay Advisory Services's Haemonetics position peaked at $26K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.